Yousif Capital Management LLC cut its holdings in shares of Cabot Co. (NYSE:CBT – Free Report) by 4.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 19,263 shares of the specialty chemicals company’s stock after selling 827 shares during the period. Yousif Capital Management LLC’s holdings in Cabot were worth $1,759,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the business. Barclays PLC lifted its holdings in shares of Cabot by 103.9% during the third quarter. Barclays PLC now owns 113,614 shares of the specialty chemicals company’s stock worth $12,699,000 after purchasing an additional 57,907 shares during the period. Franklin Resources Inc. acquired a new position in Cabot during the 3rd quarter worth about $654,000. Harbor Capital Advisors Inc. grew its position in shares of Cabot by 20.8% in the 4th quarter. Harbor Capital Advisors Inc. now owns 40,394 shares of the specialty chemicals company’s stock valued at $3,688,000 after buying an additional 6,950 shares during the last quarter. Orion Portfolio Solutions LLC acquired a new stake in shares of Cabot in the third quarter valued at about $609,000. Finally, Ritholtz Wealth Management raised its position in shares of Cabot by 165.5% during the fourth quarter. Ritholtz Wealth Management now owns 5,543 shares of the specialty chemicals company’s stock worth $506,000 after acquiring an additional 3,455 shares during the last quarter. 93.18% of the stock is owned by institutional investors.
Analysts Set New Price Targets
CBT has been the subject of a number of recent analyst reports. StockNews.com downgraded shares of Cabot from a “buy” rating to a “hold” rating in a research report on Monday. Mizuho decreased their price objective on shares of Cabot from $122.00 to $110.00 and set an “outperform” rating for the company in a research report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. downgraded shares of Cabot from a “neutral” rating to an “underweight” rating and set a $105.00 target price for the company. in a research note on Monday, November 11th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $102.00.
Cabot Price Performance
Shares of CBT opened at $86.00 on Wednesday. The firm has a market cap of $4.66 billion, a PE ratio of 11.42, a price-to-earnings-growth ratio of 0.76 and a beta of 1.19. Cabot Co. has a 52-week low of $78.61 and a 52-week high of $117.46. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.36 and a current ratio of 2.00. The business’s 50 day moving average price is $92.47 and its two-hundred day moving average price is $101.62.
Cabot (NYSE:CBT – Get Free Report) last issued its earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. On average, equities analysts anticipate that Cabot Co. will post 7.57 EPS for the current year.
Cabot Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Friday, February 28th will be given a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date is Friday, February 28th. Cabot’s payout ratio is 22.84%.
Cabot declared that its Board of Directors has initiated a stock repurchase program on Tuesday, December 3rd that permits the company to repurchase 10,000,000 outstanding shares. This repurchase authorization permits the specialty chemicals company to buy shares of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its shares are undervalued.
Cabot Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Recommended Stories
- Five stocks we like better than Cabot
- What is an Earnings Surprise?
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- What Are Growth Stocks and Investing in Them
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.